Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study by Miheller, Pál, Lakatos, Péter L, Horváth, Gábor, Molnár, Tamás, Szamosi, Tamás, Czeglédi, Zsófia, Salamon, Agnes, Czimmer, József, Rumi, György, Palatka, Károly, Papp, Mária, Jakab, Zsolt, Szabó, Andrea, Gelley, András, Lakatos, László, Barta, Zsolt, Balázs, Csaba, Rácz, István, Zeher, Margit, Döbrönte, Zoltán, Altorjay, István, Hunyady, Béla, Simon, László, Papp, János, Banai, János, Nagy, Ferenc, Lonovics, János, Ujszászy, László, Muzes, Györgyi, Herszényi, László, Tulassay, Zsolt

Get full text

Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease by Lakatos, Peter Laszlo, Czegledi, Zsofia, Szamosi, Tamas, Banai, Janos, David, Gyula, Zsigmond, Ferenc, Pandur, Tunde, Erdelyi, Zsuzsanna, Gemela, Orsolya, Papp, Janos, Lakatos, Laszlo

Get full text

Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease by Lakatos, Peter Laszlo, Czegledi, Zsofia, David, Gyula, Kispal, Zsofia, Kiss, Lajos S, Palatka, Karoly, Kristof, Tunde, Nagy, Ferenc, Salamon, Agnes, Demeter, Pal, Miheller, Pal, Szamosi, Tamas, Banai, Janos, Papp, Maria, Bene, Laszlo, Kovacs, Agota, Racz, Istvan, Lakatos, Laszlo

Get full text

Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn＇s disease by Peter Laszlo Lakatos Zsofia Czegledi Tamas Szamosi Janos Banai Gyula David Ferenc Zsigmond Tunde Pandur Zsuzsanna Erdelyi Orsolya Gemela Janos Papp Laszlo Lakatos

Get full text